P34 The effect of sex on the efficacy and safety of dabigatran dual therapy in atrial fibrillation after PCI: a subgroup analysis from the RE-DUAL PCI trial

Published on Aug 1, 2018in European Heart Journal22.673

· DOI :10.1093/EHJCI/EHZ872.031

David Eccleston13

Estimated H-index: 13

(University of Melbourne), J. M. ten Berg18

Estimated H-index: 18

+ 9 AuthorsJonas Oldgren14

Estimated H-index: 14

Abstract

📖 Papers frequently viewed together

P5333Dual antithrombotic therapy with dabigatran vs triple therapy with warfarin after PCI in patients with atrial fibrillation and diabetes mellitus (a RE-DUAL PCI subgroup analysis)

201822.67European Heart Journal

12 Authors (Michael Maeng, ..., Investigators)

RELATION OF STROKE AND BLEEDING RISK PROFILES TO EFFICACY AND SAFETY OF DABIGATRAN IN ATRIAL FIBRILLATION AFTER PCI: AN ANCILLARY ANALYSIS FROM THE RE-DUAL PCI TRIAL

201820.59Journal of the American College of Cardiology

14 Authors (Gregory Y.H. Lip, ..., Christopher Cannon)

Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCI

20198.43Jacc-cardiovascular Interventions

15 Authors (Stefan H. Hohnloser, ..., Investigators)

References0

Newest

Cited By0

Newest